FOXO Technologies

Minneapolis, United States Founded: 2020 • Age: 6 yrs
Epigenetic biomarkers are discovered and developed via AI platforms.
Annual revenue $4.0M Latest available
Total funding - 11 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About FOXO Technologies

FOXO Technologies is a company based in Minneapolis (United States) founded in 2020. It operates as a HealthTech and Managed Services. FOXO Technologies offers products and services including Epigenetic Diagnostics, Rural Hospitals, and Mental Health Facilities. FOXO Technologies operates in a competitive market with competitors including Chroma Medicine, Reaction Biology, Chronomics, Epsilen Bio and Epigenica, among others.

  • Headquarter Minneapolis, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Foxo Technologies Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $4.02 M (USD)
    797.47
    as on Dec 31, 2024
  • Net Profit
    -$12.41 M (USD)
    53.1
    as on Dec 31, 2024
  • EBITDA
    Not available
  • Latest Funding Round
    $1.65 M (USD), Post-IPO

    Jun 03, 2025

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of FOXO Technologies

FOXO Technologies is a publicly listed company on the OTC with ticker symbol FOXO in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OTC · Ticker: FOXO · Sector: Technology services · USA

Products & Services of FOXO Technologies

FOXO Technologies offers a comprehensive portfolio of products and services, including Epigenetic Diagnostics, Rural Hospitals, and Mental Health Facilities.

Product name locked
Category locked
Primary

Epigenetic diagnostics are provided for health insights and analysis.

Product name locked
Category locked
Locked

Rural hospitals are operated to serve community health needs.

Product name locked
Category locked
Locked

Mental health facilities are managed for behavioral health support.

People of FOXO Technologies

Headcount 50-200
Employee Profiles 3
Board Members and Advisors 3
Employee Profiles
People
Carley Anderson
Operations Associate
People
Brenda Lidke
Financial Consultant
People
Murdoc Khaleghi
Board Of Directors, Chief Medical Officer

Unlock access to complete

Funding Insights of FOXO Technologies

Investors in FOXO Technologies

FOXO Technologies has secured backing from 1 investor. Prominent investors backing the company include Bespoke Growth Partners, Inc.

All
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Premium access

Investor details for FOXO Technologies

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by FOXO Technologies

Investments
Premium access

Investment portfolio details for FOXO Technologies

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - FOXO Technologies

Premium access

Detailed financials for FOXO Technologies

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Foxo Technologies Comparisons

FOXO Technologies Primary company
Description
Epigenetic biomarkers are discovered and developed via AI pl...
Location
Minneapolis, United States
Founded Year
2020
Annual Revenue
$4.02 M (USD)
Net Profit
-$12.41 M (USD)
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for FOXO Technologies

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of FOXO Technologies

FOXO Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, Reaction Biology, Chronomics, Epsilen Bio and Epigenica, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Epigenetic editing platform is developed for genomic medicines.
Locked Locked Locked
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
Locked Locked Locked
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
Locked Locked Locked
Epigenetic gene silencing technologies are developed for disease treatments.
Locked Locked Locked
Provider of solutions for the analysis of genomic data
Premium access

Detailed competitors of FOXO Technologies

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Foxo Technologies

Premium access

Complete news archive for FOXO Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FOXO Technologies

FOXO Technologies was founded in 2020 and raised its 1st funding round 1 year after it was founded.

FOXO Technologies is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.

Annual revenue of FOXO Technologies is $4.02M as on Dec 31, 2024.

FOXO Technologies, Inc. is involved in healthcare services and technology through three divisions. Epigenetic diagnostics and interpretation are provided for advanced health insights. Rural hospitals are operated to address community healthcare needs. Mental and behavioral health facilities are managed to support patient well-being. Each division is run by wholly owned subsidiaries, focusing on innovation-driven solutions for critical healthcare provider needs across various sectors.

FOXO Technologies's top competitors include Chroma Medicine, Chronomics and Reaction Biology.

FOXO Technologies offers Epigenetic Diagnostics, Rural Hospitals, and Mental Health Facilities.

Yes, FOXO Technologies is publicly traded on OTC under the ticker symbol FOXO.

FOXO Technologies has 1 investor. Key investors include Bespoke Growth Partners, Inc.

The ticker symbol of FOXO Technologies is FOXO on OTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available